甘精胰岛素治疗组的治疗满意度更高。
Patients treated with GLAR reported significantly higher treatment satisfaction.
目的探讨甘精胰岛素对糖尿病大鼠心肌的保护作用。
Objective To investigate the protective effect of insulin glargine in myocardium of diabetic rats.
您能就甘精胰岛素和癌症风险之间的关系说一下您的观点吗？
Can you give us your perspective on the relationship between insulin glargine and cancer risk?
结论甘精胰岛素强化治疗可以良好地控制高血糖，且低血糖发生率低。
Conclusions Insulin Glargine intensification therapy can control high blood sugar well and the incidence of hypoglycemia is low.
甘精胰岛素和人体胰岛素相似，用于1型和2型糖尿病患者的血糖控制。
Similar to human insulin, insulin glargine is used to control blood sugar in people with Type 1 and Type 2 diabetes.
目的探讨使用甘精胰岛素进行2型糖尿病患者围手术期血糖控制的可行性。
Objective To investigate the feasibility of perioperative glycemic control with insulin glargine in type 2 diabetic patients.
研究目的：回顾240名使用甘精胰岛素做基础治疗的糖尿病孕妇的产科结局。
To review the obstetric outcome of 240 diabetic pregnancies maintained on basal glargine insulin.
目的比较住院患者使用甘精胰岛素和中性鱼精蛋白锌胰岛素控制血糖达标的成本。
Objective To compare the administration cost of glargine and neutral protamine hagedorn in glycemic control.
虽然有大量的糖尿病孕妇在使用甘精胰岛素，但没有明确的研究来确认它的好处。
Although there is considerable use of Glargine in pregnant diabetic women, there is no definitive study to confirm its benefits.
显然，它是一个信号，在甘精胰岛素长期使用者中可能有关于乳腺癌的某种事情正在进行。
Clearly it's a signal that there may be something going on here with breast cancer in the long-term users of insulin glargine.
结果两组血糖均明显下降，甘精胰岛素组下降更平稳，血糖波动性更小，低血糖事件更少。
Results Two groups of blood glucose were significantly decreased, insulin glargine group drop more smoothly, blood sugar volatility smaller, hypoglycemia event less.
对于明显缺乏胰岛素峰值和长期应用的住院治疗及手术后患者使用甘精胰岛素是有效果的。
Insulin Glargine is effective in hospitalized and postsurgical patients on account of its lack of pronounced insulin peaks and long duration of action.
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
甘精胰岛素是一种安全、有效的长效基础胰岛素类似物，用于糖尿病人的基础血糖控制治疗。
Insulin glargine is a safe, effective and long-acting insulin analogue. It can provide prolonged basal glucose control in patients with diabetes mellitus.
而且，各项研究所得出的结论也不一致，从而使人怀疑使用甘精胰岛素和癌症之间是否存在联系。
Further, inconsistencies in findings within and across individual studies raise concerns as to whether an association between the use of insulin glargine and cancer truly exists.
甘精胰岛素较中性鱼精蛋白锌胰岛素的主要优势是较少发生低血糖反应，从而具有较好的安全性。
The principal advantage of insulin Glargine over neutral protamine Hagedorn (NPH) insulin is in a lower frequency of hypoglycemic reactions, thus affording improved safety.
虽然甘精胰岛素通常是用于夜间使用的，但为了方便病人也可以在上午或在其他任何需要的时间内使用。
Although insulin Glargine is typically administered as a single nighttime dose, it can be given in the morning or at any other time convenient for the patient.
这种疗法的成本可能较低，但甘精胰岛素的主要优点是低血糖反应有较低的发生率，使其具有更大的安全性。
Such a therapy may be less costly, but the major advantage of insulin Glargine remains the greater safety of a lower frequency of hypoglycemic reactions.
其次，新的基础类似物，无论是地特或甘精胰岛素，均已证实事实上并不增加体重，因为它们是基础胰岛素。
Secondly, the new basal analogues, whether it is detemir or glargine, have shown that they do not substantially increase weight because they are basal insulin.
在肥胖的胰岛素耐受患者中由于需要注射大量的胰岛素，给予两个不同剂量的甘精胰岛素可能是最好的方法。
In obese, insulin-resistant patients, it may be best to administer insulin Glargine in two separate doses, owing to the high volumes of injected insulin required.
然而，甘精胰岛素是经过修饰的人胰岛素(即胰岛素类似物)，可以提供更长时间的血糖控制(长效胰岛素)。
Insulin glargine, however, is a modified version of human insulin (an insulin analogue) that allows for the control of blood sugar for extended periods of time (a long-acting insulin).
背景和目的：甘精胰岛素是一种在血液胰岛素水平中吸收常数无明显峰值并且作用持续24小时的基础胰岛素。
BACKGROUND and OBJECTIVE: insulin glargine as a basal insulin exhibits constant absorption with no pronounced peaks in blood insulin levels and 24-h duration of action.
甘精胰岛素是胰岛素的类似物，可以使患者在获得较好血糖控制的同时较少发生低血糖反应，但其价格相对较高。
Insulin glargine is an insulin analogue which has better glucose control and less hypoglycemic episodes, but has higher price.
CHMP的评论者们发现这些研究无论在证实或排除甘精胰岛素与癌症的联系方面都不够严密，且这些研究彼此的结果并不一致。
The CHMP reviewers found that the studies were not rigorous enough to either confirm or rule out a relationship between glargine and cancer, and the results were not consistent among the studies.
诺和诺德公司表示长效基础胰岛素Degludec的后期实验显示，该药物和甘精胰岛素相比，能够显著减少病人在夜间血糖过低的风险。
The company said a late-stage study of its insulin Degludec showed it “significantly reduces risk” of hypoglycemia during the night compared with glargine.
诺和诺德公司表示长效基础胰岛素Degludec的后期实验显示，该药物和甘精胰岛素相比，能够显著减少病人在夜间血糖过低的风险。
The company said a late-stage study of its insulin Degludec showed it “significantly reduces risk” of hypoglycemia during the night compared with glargine.
应用推荐